NCT04955210 A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children
| NCT ID | NCT04955210 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Critical Illness |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2022-04-30 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2022-04-30 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
1\. To research the current situation of severe infection in children in China, and to investigate the incidence, prognosis and disease burden of severe infection in children in different regions of China. 2. Establish the risk prediction model and diagnosi model of severe infection in children, and verify the accuracy of the model in multi-center; 3. To study the effectiveness and safety of different treatments in real diagnosis and treatment, and to evaluate the efficacy of subgroups under different ages and high risk factors.
Eligibility Criteria
Inclusion Criteria: 1. Children between 0 and 18 years old. 2. Severe pneumonia and/or sepsis. Exclusion Criteria: 1. notifiable infectious diseases. 2. The researcher believes that he is not suitable to participate in other situations in this study. 3. Participants in other clinical trials in the same period.
Contact & Investigator
Guoping Lu
PRINCIPAL INVESTIGATOR
Children's Hospital of Fudan University
Frequently Asked Questions
Who can join the NCT04955210 clinical trial?
This trial is open to participants of all sexes, aged 29 Days or older, up to 18 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04955210 currently recruiting?
Yes, NCT04955210 is actively recruiting participants. Contact the research team at 13788904150@163.com for enrollment information.
Where is the NCT04955210 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04955210 clinical trial?
NCT04955210 is sponsored by Children's Hospital of Fudan University. The principal investigator is Guoping Lu at Children's Hospital of Fudan University. The trial plans to enroll 5,000 participants.